Abstract：
Treatment of patients with advanced heart failure (HF) with the use of left ventricular assist devices (LVADs) improves the quality of life and the length of survival. Despite the undeniable benefits associated with improved physical performance, as a result of the decrease of the underlying disease symptoms, it carries the risk of complications in the area of the patient\'s somatic and psychological status. Long-term circulatory failure can contribute to a weakening of the adaptative mechanism and consequently lead to a variety of emotional disruptions. Patients must face the fear of imminent physical, family, and social changes that LVAD requires. They may experience sleep disorders, mood disorders, anxiety disorders, and in the early postoperative period also disorders of consciousness with a pattern of delirium. For this reason, it is advisable to provide multidisciplinary medical care for the patient at all stages of treatment, including regular monitoring of general health and mental health. This article presents risk factors for psychiatric disorders in patients with LVADs and ways of pharmacological and non-pharmacological management when these factors are identified and disorders are diagnosed.
摘要：
使用左心室辅助装置（LVAD）治疗晚期心力衰竭（HF）的患者可改善生活质量和生存时间。尽管与改善物理性能相关的不可否认的好处，由于潜在疾病症状的减少，它在患者的躯体和心理状态方面具有并发症的风险。长期的循环衰竭可能会削弱适应机制，从而导致各种情绪中断。患者必须面对迫在眉睫的身体恐惧，家庭,以及LVAD需要的社会变革。他们可能会经历睡眠障碍，情绪障碍,焦虑症,在术后早期，意识障碍也伴有谵妄。出于这个原因,建议在治疗的所有阶段为患者提供多学科医疗服务，包括定期监测一般健康和心理健康。本文介绍了LVAD患者精神疾病的危险因素，以及确定这些因素并诊断出疾病时的药理学和非药理学管理方法。
